| Line Item | 2024-02-29 | Y/Y |
|---|---|---|
| Revenue | $853.0M | +30.0% |
| Cost of Revenue | $333.0M | +40.5% |
| Gross Profit | $520.0M | +24.1% |
| R&D Expense | $186.0M | -10.1% |
| SG&A Expense | $181.0M | -46.8% |
| Operating Income | -$125.0M | +82.8% |
| Interest Expense | $6.0M | +0.0% |
| Pre-tax Income | -$106.0M | +85.3% |
| Income Tax | $24.0M |
| Line Item | 2024-02-29 | Y/Y |
|---|---|---|
| Cash & Equivalents | $175.0M | -40.7% |
| Short-term Investments | $62.0M | -52.7% |
| Accounts Receivable | $199.0M | +65.8% |
| Current Assets | $508.0M | -31.6% |
| Total Assets | $1.40B | -16.9% |
| Current Liabilities | $356.0M | -51.2% |
| Long-term Debt | $194.0M | — |
| Line Item | 2024-02-29 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.0M | +98.9% |
| Capital Expenditures | $7.0M | +0.0% |
| Investing Cash Flow | $46.0M | -73.9% |
| Financing Cash Flow | -$165.0M | -2850.0% |
| Free Cash Flow | -$10.0M | +96.3% |
| +71.4% |
| Net Income | -$130.0M | +82.3% |
| EPS (Basic) | -$0.22 | +82.7% |
| EPS (Diluted) | -$0.22 | +83.7% |
| Total Liabilities |
| $619.0M |
| -24.7% |
| Stockholders' Equity | $776.0M | -9.5% |